Sativex® commercialisation approval in Italy

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Sativex® commercialisation approval in Italy

Postby MSUK » Tue May 07, 2013 2:08 am

GW Pharmaceuticals plc has announced that it has received commercialisation approval for its prescription medicine Sativex® in Italy. A full marketing authorization has been granted by the authorities in Italy for the treatment of moderate to severe spasticity in Multiple Sclerosis (MS) patients who have not responded adequately to other anti-spasticity medications....... Read More -
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Sativex


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service